When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
FOMX - With 2 NDAs Already Submitted To The FDA Foamix Sets Itself Up For A Monumental Period
Foamix Pharmaceuticals Ltd.
Foamix Pharmaceuticals (FOMX) is a biotech that should be on everyone's radar, especially as it approaches to potentially have 2 FDA approvals under its belt. This involves the NDA that was filed just this past week for FMX103 to treat moderate to severe papulopustular rosacea. On top of that, the company has already submitted an NDA for FMX101 to treat acne vulgaris as well. A PDUFA date for FMX101 has been established for October 20, 2019. Both of these drugs being approved would transform the company from clinical stage biotech to a full-fledged